GORE® HELEX® Septal Occluder / GORE® CARDIOFORM Septal Occluder for Patent Foramen Ovale (PFO) Closure in Stroke Patients - The Gore REDUCE Clinical Study (HLX 06-03)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00738894
Recruitment Status : Active, not recruiting
First Posted : August 21, 2008
Last Update Posted : August 18, 2017
Information provided by (Responsible Party):
W.L.Gore & Associates

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : April 24, 2017
  Estimated Study Completion Date : February 2020

Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 May 16, 2018
June 15, 2018
Publications automatically indexed to this study by Identifier (NCT Number):